DSM Venturing and Strategic Health Investment Partners extended the Stanford cartilage replacement spinout's series A round, augmenting a $16m first close featuring Johnson & Johnson and Osage University Partners.

Hyalex Orthopaedics, a US-based cartilage replacement material spinout of Stanford University, increased its series A round from $16m to $33m yesterday. The additional funding came from investors including DSM Venturing, the open innovation arm of health, nutrition and material product supplier DSM, and medical device-focused venture capital firm Strategic Health Investment Partners. The new funding…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.